The term "low-grade inflammation" may sound somewhat reassuring, but it's actually a key concept that can impact the health of our hearts in surprising ways. This article delves into the connection between low-grade inflammation and cardiovascular diseases, seeking to understand how these processes affect the well-being of our cardiovascular system.
Fasting blood glucose and glycated hemoglobin are commonly used parameters to diagnose diabetes. However, normal values of these traditional indicators do not allow us to detect sugar-related damage early, which always precedes the subsequent development of diabetes in a detectable manner.
Arthritis is a widespread condition that affects joints, tendons, ligaments, and muscle fascia, causing pain and stiffness. Regardless of the underlying causes, all forms of arthritis are linked to local or systemic inflammation.
The protein BAFF (B cell Activating Factor) has been known to the scientific community for well over a decade, and numerous studies have elucidated its involvement in various processes as well as its potential relationships with inflammation, including inflammation related to diet.
For a long time, ESR and CRP have been the primary biomarkers for assessing inflammation. However, these "acute-phase" proteins have limitations in specificity and sensitivity for identifying low-grade inflammation. Other biomarkers, such as BAFF and PAF, which are linked to specific immune pathways, are more accurate for this type of inflammation.
Preventing diabetes by identifying genetic predispositions and lifestyle factors can significantly add healthy years of life. A personalized medicine approach is crucial to enhance quality of life and well-being, allowing occasional indulgences without compromising health.
